LAS VEGAS, April 14, 2017 /PRNewswire/ -- The International Society for CNS Drug Development (ISCDD) announced today thatRaymond Sanchez, M.D., Senior Vice President, Global Clinical Development at Otsuka Pharmaceutical Development & Commercialization (OPDC), has been elected as the Chairman of the Executive Committee for the ISCDD.
"For the past fifteen years, the ISCDD has played a significant role in shaping the present and future development of CNS therapies," said Dr. Sanchez. "I am committed to continue to help make strides with others in CNS endeavors and look forward to substantial progress over the next four years as we incorporate and leverage innovative approaches to development."
The International Society for CNS Drug Development (ISCDD) is a non-profit, independent leadership forum founded in 2002 to improve central nervous system drug development through collaboration amongst stakeholders including industry, academia, and government.
For more information, please contact:
Erica Moore ISCDD Secretariat O: 702-992-0784 M: 610-613-3524 [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/raymond-sanchez-elected-chairman-of-iscdd-executive-committee-at-iscdd-2017-annual-meeting-300439814.html
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All